Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ART558
i
Other names:
ART558
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Artios Pharma
Drug class:
POLQ inhibitor
Related drugs:
‹
VP-006 (2)
ART4215 (0)
ART6043 (0)
RP-2119 (0)
VP-006 (2)
ART4215 (0)
ART6043 (0)
RP-2119 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA1 mutation
Solid Tumor
BRCA1 mutation
Solid Tumor
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
BRCA2 mutation
Solid Tumor
BRCA2 mutation
Solid Tumor
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
ATM deletion
Mantle Cell Lymphoma
ATM deletion
Mantle Cell Lymphoma
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
ART558
Sensitive: D – Preclinical
ART558
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login